Univest Financial’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $16.3M | Sell |
33,259
-1,144
| -3% | -$621K | 0.92% | 23 |
|
|
2025
Q4 | $19.9M | Sell |
34,403
-1,112
| -3% | -$629K | 1.06% | 20 |
|
|
2025
Q3 | $17.2M | Buy |
35,515
+4,071
| +13% | +$1.89M | 0.96% | 19 |
|
|
2025
Q2 | $12.7M | Buy |
31,444
+107
| +0.3% | +$44.7K | 0.77% | 29 |
|
|
2025
Q1 | $15.6M | Sell |
31,337
-8,439
| -21% | -$4.57M | 1.02% | 20 |
|
|
2024
Q4 | $20.7M | Sell |
39,776
-5,410
| -12% | -$2.97M | 1.31% | 17 |
|
|
2024
Q3 | $28M | Buy |
45,186
+33,961
| +303% | +$20.1M | 1.84% | 10 |
|
|
2024
Q2 | $6.21M | Buy |
11,225
+110
| +1% | +$63K | 1.72% | 15 |
|
|
2024
Q1 | $6.46M | Buy |
11,115
+760
| +7% | +$426K | 1.82% | 15 |
|
|
2023
Q4 | $5.5M | Sell |
10,355
-287
| -3% | -$139K | 1.63% | 20 |
|
|
2023
Q3 | $5.39M | Buy |
10,642
+389
| +4% | +$207K | 1.8% | 17 |
|
|
2023
Q2 | $5.35M | Buy |
10,253
+25
| +0.2% | +$13.5K | 1.62% | 18 |
|
|
2023
Q1 | $5.9M | Sell |
10,228
-249
| -2% | -$140K | 1.84% | 13 |
|
|
2022
Q4 | $5.77M | Sell |
10,477
-168
| -2% | -$89K | 1.82% | 14 |
|
|
2022
Q3 | $5.4M | Buy |
10,645
+981
| +10% | +$549K | 1.77% | 15 |
|
|
2022
Q2 | $5.25M | Buy |
9,664
+106
| +1% | +$58.3K | 1.71% | 16 |
|
|
2022
Q1 | $5.65M | Sell |
9,558
-1,499
| -14% | -$861K | 1.59% | 20 |
|
|
2021
Q4 | $7.38M | Sell |
11,057
-300
| -3% | -$187K | 1.88% | 15 |
|
|
2021
Q3 | $6.49M | Sell |
11,357
-269
| -2% | -$148K | 1.81% | 18 |
|
|
2021
Q2 | $5.87M | Sell |
11,626
-443
| -4% | -$209K | 1.61% | 19 |
|
|
2021
Q1 | $5.51M | Sell |
12,069
-82
| -0.7% | -$39.1K | 1.55% | 22 |
|
|
2020
Q4 | $5.66M | Sell |
12,151
-1,336
| -10% | -$626K | 1.64% | 18 |
|
|
2020
Q3 | $5.96M | Sell |
13,487
-718
| -5% | -$297K | 1.88% | 14 |
|
|
2020
Q2 | $5.15M | Sell |
14,205
-1,249
| -8% | -$419K | 1.7% | 17 |
|
|
2020
Q1 | $4.38M | Buy |
+15,454
| New | +$4.87M | 1.74% | 11 |
|
|
2019
Q4 | – | Sell |
-17,690
| Closed | -$5.15M | – | 128 |
|
|
2019
Q3 | $5.15M | Sell |
17,690
-9
| -0.1% | -$2.58K | 1.65% | 13 |
|
|
2019
Q2 | $5.2M | Sell |
17,699
-110
| -0.6% | -$30.3K | 1.65% | 12 |
|
|
2019
Q1 | $4.88M | Sell |
17,809
-1,079
| -6% | -$269K | 1.6% | 12 |
|
|
2018
Q4 | $4.23M | Buy |
18,888
+7
| +0% | +$1.64K | 1.56% | 17 |
|
|
2018
Q3 | $4.61M | Sell |
18,881
-572
| -3% | -$132K | 1.41% | 21 |
|
|
2018
Q2 | $4.03M | Sell |
19,453
-816
| -4% | -$173K | 1.61% | 26 |
|
|
2018
Q1 | $4.18M | Sell |
20,269
-484
| -2% | -$102K | 1.81% | 25 |
|
|
2017
Q4 | $3.94M | Buy |
20,753
+435
| +2% | +$83.3K | 1.59% | 32 |
|
|
2017
Q3 | $3.84M | Sell |
20,318
-711
| -3% | -$129K | 1.62% | 28 |
|
|
2017
Q2 | $3.67M | Buy |
21,029
+631
| +3% | +$106K | 1.54% | 30 |
|
|
2017
Q1 | $3.13M | Buy |
+20,398
| New | +$3.12M | 1.37% | 37 |
|
Other funds holding TMO
VCM
Univest Financial's TMO Position: Q1 2026 in Review
Univest Financial reduced its Thermo Fisher Scientific (TMO) stake by 3.3% in Q1 2026, selling an estimated $621K and leaving 33,259 shares worth $16.3M. The position accounts for 0.92% of the portfolio, ranked #23.
Univest Financial first reported a position in TMO in Q1 2017 and has held it in 36 quarters since. The position peaked at $28M in Q3 2024. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Univest Financial held 33,259 shares of Thermo Fisher Scientific worth $16.3M as of Q1 2026.
- Univest Financial sold 1,144 Thermo Fisher Scientific shares in Q1 2026, an estimated $621K.
- Thermo Fisher Scientific made up 0.92% of Univest Financial's portfolio in Q1 2026, its #23 holding.
- Univest Financial first reported a position in Thermo Fisher Scientific in Q1 2017 and has held it in 36 quarters since.
- Univest Financial's Thermo Fisher Scientific position peaked at $28M in Q3 2024.
- 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Univest Financial's 13F filing for Q1 2026, filed 1 May 2026.